Charles Williams
Vermogen: 473 250 $ op 30-06-2026
Vermogen: 473 250 $ op 30-06-2026
Charles Williams is Secretary & Chief Operating Officer at Surrozen, Inc. since 2025.
Formerly, Mr. Williams was Head-Corporate Development at Jazz Pharmaceuticals Plc from 2013 to 2020 and Director-Corporate & Business Development at MAP Pharmaceuticals LLC from 2008 to 2013.
Mr. Williams completed undergraduate education at Cornell University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SURROZEN INC 0,16% | 15-06-2026 | 18.237 ( 0,16% ) | 473 250 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SURROZEN, INC. | Operationeel Directeur | 01-02-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01-11-2020 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Corporate Officer/Principal | 01-01-2013 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Surrozen, Inc.
Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau